| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +415.09% | -0.46% | +415.56% | +415.56% | — |
| 14d | 1 | +0.00% | +371.70% | -1.40% | +373.10% | +373.10% | — |
| 30d | 1 | +0.00% | +208.49% | -3.60% | +212.09% | +212.09% | — |
| 60d | 1 | +0.00% | +341.51% | +5.93% | +335.58% | +335.58% | — |
| 90d | 1 | +0.00% | +308.49% | — | — | — | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ANTX AN2 THERAPEUTICS, INC. | SALE Principal Accounting Officer | 265 | $4.43 | $1.2K | 66,583 | May 29, 2026 | Jun 2, 2026 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | SALE Principal Accounting Officer | 327 | $1.06 | $347 | 66,848 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| ANTX AN2 THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 48,375 | — | — | 67,175 | Feb 20, 2026 | Feb 23, 2026 ↗ | View → |